RETREATMENT WITH DOCETAXEL (DOC) - BASED CHEMOTHERAPY IN PATIENTS (PTS) WITH HORMONE-REFRACTORY PROSTATE CANCER (HRPC) WHO HAVE RESPONDED TO THE FIRST-LINE DOC: A MONO-INSTITUTIONAL EXPERIENCE

ANNALS OF ONCOLOGY(2009)

引用 0|浏览10
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要